冷冻IVF/ICSI周期中黄体支持方案的比较:网络荟萃分析

IF 4.7 1区 医学 Q1 OBSTETRICS & GYNECOLOGY
Neerujah Balachandren, Meenakshi Veeramani, Sureka Suriyakumar, Sarah Wiley, Dimitrios Mavrelos, Ephia Yasmin, Stavroula L. Kastora
{"title":"冷冻IVF/ICSI周期中黄体支持方案的比较:网络荟萃分析","authors":"Neerujah Balachandren,&nbsp;Meenakshi Veeramani,&nbsp;Sureka Suriyakumar,&nbsp;Sarah Wiley,&nbsp;Dimitrios Mavrelos,&nbsp;Ephia Yasmin,&nbsp;Stavroula L. Kastora","doi":"10.1111/1471-0528.18172","DOIUrl":null,"url":null,"abstract":"<div>\n \n \n <section>\n \n <h3> Background</h3>\n \n <p>Luteal support is a core success factor of frozen embryo transfers (FET). However, inconsistency across recommended protocols generates notable heterogeneity across reproductive outcomes.</p>\n </section>\n \n <section>\n \n <h3> Objective</h3>\n \n <p>To determine the most effective luteal support strategy (LPS) based on five key factors related to the effectiveness of FET cycles.</p>\n </section>\n \n <section>\n \n <h3> Search Strategy</h3>\n \n <p>Twelve databases and two prospective registers were searched from inception to 1st January 2024. The study was prospectively registered under the PROSPERO database (CRD42024513549).</p>\n </section>\n \n <section>\n \n <h3> Selection Criteria</h3>\n \n <p>Randomised Controlled Trials (RCTs) and observational studies of women undergoing frozen embryo transfers were included.</p>\n </section>\n \n <section>\n \n <h3> Data Collection and Analysis</h3>\n \n <p>Bayesian network meta-analysis (NMA) model presenting random effects, risk ratios (RRs) with 95% credibility intervals (CrIs) was employed. Primary outcomes included clinical pregnancy, live birth, and miscarriage. Secondary outcomes included biochemical pregnancy and multiple pregnancy events.</p>\n </section>\n \n <section>\n \n <h3> Main Results</h3>\n \n <p>Fourteen studies, of which eight RCTs, comparing 12 interventions upon 4688 participants, were included. Overall, CiNeMa risk of bias was moderate, and network inconsistency per outcome was low. Thirteen studies reported on clinical pregnancy events with vaginal progesterone (VP) and a single or double dose of subcutaneous GnRH agonist (GnRHa), significantly improving clinical pregnancy, RR 1.86 [95% CrI 1.18, 2.93].</p>\n </section>\n \n <section>\n \n <h3> Conclusions</h3>\n \n <p>The addition of 0.1 mg subcutaneous GnRH agonist in a single (Day 3 post ET) or double (Day 3 and Day 6 post ET) schema upon a vaginal progesterone regimen till Week 12 appears to improve clinical pregnancy events in FET cycles.</p>\n </section>\n </div>","PeriodicalId":50729,"journal":{"name":"Bjog-An International Journal of Obstetrics and Gynaecology","volume":"132 9","pages":"1187-1201"},"PeriodicalIF":4.7000,"publicationDate":"2025-05-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/1471-0528.18172","citationCount":"0","resultStr":"{\"title\":\"Comparison of Luteal Support Protocols in Frozen IVF/ICSI Cycles: A Network Meta-Analysis\",\"authors\":\"Neerujah Balachandren,&nbsp;Meenakshi Veeramani,&nbsp;Sureka Suriyakumar,&nbsp;Sarah Wiley,&nbsp;Dimitrios Mavrelos,&nbsp;Ephia Yasmin,&nbsp;Stavroula L. Kastora\",\"doi\":\"10.1111/1471-0528.18172\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div>\\n \\n \\n <section>\\n \\n <h3> Background</h3>\\n \\n <p>Luteal support is a core success factor of frozen embryo transfers (FET). However, inconsistency across recommended protocols generates notable heterogeneity across reproductive outcomes.</p>\\n </section>\\n \\n <section>\\n \\n <h3> Objective</h3>\\n \\n <p>To determine the most effective luteal support strategy (LPS) based on five key factors related to the effectiveness of FET cycles.</p>\\n </section>\\n \\n <section>\\n \\n <h3> Search Strategy</h3>\\n \\n <p>Twelve databases and two prospective registers were searched from inception to 1st January 2024. The study was prospectively registered under the PROSPERO database (CRD42024513549).</p>\\n </section>\\n \\n <section>\\n \\n <h3> Selection Criteria</h3>\\n \\n <p>Randomised Controlled Trials (RCTs) and observational studies of women undergoing frozen embryo transfers were included.</p>\\n </section>\\n \\n <section>\\n \\n <h3> Data Collection and Analysis</h3>\\n \\n <p>Bayesian network meta-analysis (NMA) model presenting random effects, risk ratios (RRs) with 95% credibility intervals (CrIs) was employed. Primary outcomes included clinical pregnancy, live birth, and miscarriage. Secondary outcomes included biochemical pregnancy and multiple pregnancy events.</p>\\n </section>\\n \\n <section>\\n \\n <h3> Main Results</h3>\\n \\n <p>Fourteen studies, of which eight RCTs, comparing 12 interventions upon 4688 participants, were included. Overall, CiNeMa risk of bias was moderate, and network inconsistency per outcome was low. Thirteen studies reported on clinical pregnancy events with vaginal progesterone (VP) and a single or double dose of subcutaneous GnRH agonist (GnRHa), significantly improving clinical pregnancy, RR 1.86 [95% CrI 1.18, 2.93].</p>\\n </section>\\n \\n <section>\\n \\n <h3> Conclusions</h3>\\n \\n <p>The addition of 0.1 mg subcutaneous GnRH agonist in a single (Day 3 post ET) or double (Day 3 and Day 6 post ET) schema upon a vaginal progesterone regimen till Week 12 appears to improve clinical pregnancy events in FET cycles.</p>\\n </section>\\n </div>\",\"PeriodicalId\":50729,\"journal\":{\"name\":\"Bjog-An International Journal of Obstetrics and Gynaecology\",\"volume\":\"132 9\",\"pages\":\"1187-1201\"},\"PeriodicalIF\":4.7000,\"publicationDate\":\"2025-05-02\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://onlinelibrary.wiley.com/doi/epdf/10.1111/1471-0528.18172\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Bjog-An International Journal of Obstetrics and Gynaecology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://onlinelibrary.wiley.com/doi/10.1111/1471-0528.18172\",\"RegionNum\":1,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"OBSTETRICS & GYNECOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Bjog-An International Journal of Obstetrics and Gynaecology","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1111/1471-0528.18172","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"OBSTETRICS & GYNECOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

黄体支持是冷冻胚胎移植(FET)成功的核心因素。然而,推荐方案的不一致性导致生殖结果的显著异质性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。

Comparison of Luteal Support Protocols in Frozen IVF/ICSI Cycles: A Network Meta-Analysis

Comparison of Luteal Support Protocols in Frozen IVF/ICSI Cycles: A Network Meta-Analysis

Background

Luteal support is a core success factor of frozen embryo transfers (FET). However, inconsistency across recommended protocols generates notable heterogeneity across reproductive outcomes.

Objective

To determine the most effective luteal support strategy (LPS) based on five key factors related to the effectiveness of FET cycles.

Search Strategy

Twelve databases and two prospective registers were searched from inception to 1st January 2024. The study was prospectively registered under the PROSPERO database (CRD42024513549).

Selection Criteria

Randomised Controlled Trials (RCTs) and observational studies of women undergoing frozen embryo transfers were included.

Data Collection and Analysis

Bayesian network meta-analysis (NMA) model presenting random effects, risk ratios (RRs) with 95% credibility intervals (CrIs) was employed. Primary outcomes included clinical pregnancy, live birth, and miscarriage. Secondary outcomes included biochemical pregnancy and multiple pregnancy events.

Main Results

Fourteen studies, of which eight RCTs, comparing 12 interventions upon 4688 participants, were included. Overall, CiNeMa risk of bias was moderate, and network inconsistency per outcome was low. Thirteen studies reported on clinical pregnancy events with vaginal progesterone (VP) and a single or double dose of subcutaneous GnRH agonist (GnRHa), significantly improving clinical pregnancy, RR 1.86 [95% CrI 1.18, 2.93].

Conclusions

The addition of 0.1 mg subcutaneous GnRH agonist in a single (Day 3 post ET) or double (Day 3 and Day 6 post ET) schema upon a vaginal progesterone regimen till Week 12 appears to improve clinical pregnancy events in FET cycles.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
10.90
自引率
5.20%
发文量
345
审稿时长
3-6 weeks
期刊介绍: BJOG is an editorially independent publication owned by the Royal College of Obstetricians and Gynaecologists (RCOG). The Journal publishes original, peer-reviewed work in all areas of obstetrics and gynaecology, including contraception, urogynaecology, fertility, oncology and clinical practice. Its aim is to publish the highest quality medical research in women''s health, worldwide.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信